<DOC>
	<DOCNO>NCT01871233</DOCNO>
	<brief_summary>The Extended Access Program ( EAP ) manage access programme Perampanel . The main objective EAP ensure patient participate study E2007-A001-207 , E2007-G000-307 , E2007-G000-235 continue access perampanel time perampanel tablet become commercially available treatment Partial Onset Seizures ( POS ) country reside . This EAP consist 2 phase : - Screening : The patient start program Screening assessment complete patient qualified participation . - Treatment : Additional assessment , physical examination , dosage change clinically determine treat physician . Patients enter program dose perampanel receive end participation previous study . Doses perampanel concomitant anti-epileptic drug ( AEDs ) adjust ( i.e. , add , remove , change dose ) base clinical judgment . Treatment prescribe long clinically appropriate accord judgement treat physician approve Summary Product Characteristics ( SmPC ) . The program complete staggered fashion , country country , perampanel become commercially available treatment POS country .</brief_summary>
	<brief_title>An Extended Access Program Perampanel</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>Patients participate either Study 207 , Study 307 , Study 235 opinion treat physician , continue benefit treatment perampanel ( revise per Amendment 01 ) Patients provide informed consent applicable per local requirement . Female patient childbearing potential must agree duration program period least 1 month follow last dose perampanel abstinent commit consistent correct use medically acceptable method birth control ( e.g. , doublebarrier method [ condom plus spermicide , condom plus diaphragm spermicide ] ) Patients reside country perampanel commercially available treatment POS Female patient lactate , pregnant , plan become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>anti-epileptic drug</keyword>
	<keyword>Extended Access Program</keyword>
	<keyword>partial onset seizure</keyword>
	<keyword>Perampanel</keyword>
</DOC>